Gropp C, Lehmann F G, Bauer H W, Havemann K
Oncology. 1977;34(6):267-72. doi: 10.1159/000225240.
Levels of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), ferritin and alpha 2-pregency associated glycoprotein (alpha-2-PAG) were determined in patients with confirmed lung cancer at the time of diagnosis and in serial determinations during and after radio- or chemotherapy. Whereas AFP levels were not elevated in patients with lung cancer, increased levels of CEA, ferritin and alpha-2-PAG were found in more than 50% of the patients. The results suggest that determination of CEA, ferritin and alpha-2-PAG in the serum of patients with lung cancer may be useful to detect metastases or recurrences and to monitor the results of treatment. Furthermore, in this study CEA and ferritin could be demonstrated in extracts of lung tumor tissues by specific antisera.
在确诊时对确诊肺癌患者测定癌胚抗原(CEA)、甲胎蛋白(AFP)、铁蛋白和α2-妊娠相关糖蛋白(α-2-PAG)水平,并在放疗或化疗期间及之后进行连续测定。肺癌患者的AFP水平未升高,而超过50%的患者CEA、铁蛋白和α-2-PAG水平升高。结果表明,测定肺癌患者血清中的CEA、铁蛋白和α-2-PAG可能有助于检测转移或复发以及监测治疗效果。此外,在本研究中,通过特异性抗血清可在肺肿瘤组织提取物中检测到CEA和铁蛋白。